Researchers from UCLA have found a promising new way to help men with recurring prostate cancer live longer without their ...

Enzalutamide plus leuprolide reduces the risk of death by more than 40% in biochemically recurrent prostate cancer compared to leuprolide alone.

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

Former president Joe Biden completed a round of radiation therapy Monday, as part of his treatment for an aggressive form of ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...

WEDNESDAY, Oct. 22, 2025 (HealthDay News) — A powerful new drug combo has yielded a major breakthrough for men battling an ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...

Former United States President Joe Biden rings the cancer bell to celebrate completing a round of radiation therapy at Penn ...

Former President and Penn professor Joe Biden recently completed a round of radiation therapy to treat prostate cancer at ...

Cancer survivor Marc Hickel found relief from debilitating post-radiation complications through hyperbaric oxygen therapy at ...

Former President Joe Biden celebrated his completion of radiation therapy with family and doctors after being diagnosed with ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...